Showing posts from October, 2021

Diabetes and Exercise- #ISPAD2021 S1E2

  Exercise Management Requires an Understanding of not only “How?”, but “Why” ( and the ability to communicate this to youth )   Goals- participation, health, fitness, spontaneity, fun! Essential Message on Exercise for Youth with T1D: 1.      Activity recommendations for children and adolescents with diabetes are the same as the general population. 60 minutes/day, mix of moderate and vigorous, aerobic and weight-bearing/strengthening activity ( minimum of 3days/week) 2.     Achieving recommended levels of physical activity may be difficult due to disease complexity 3.     Specific barriers can usually be overcome with appropriate education and training. What do we need to know to manage patients and help them manage themselves? 1.     All exercise is not the same 2.     Teach the physiology of Exercise 3.     Address barriers and knowledge gaps 4.     Offer practical strategies Barriers to Exercise 1.      Lack of knowledge: Patients needs education; need to re

Diabetes and COVID-19: #ISPAD2021-S1E1

  As a #dedocvoice scholar (for the 3rd time) since 2020, I had the opportunity to attend the most extraordinary 47th ISPAD Annual Conference (October 13-15, 2021). I'm forever grateful to  #dedoc° for the amazing opportunities not only to attend but to speak. This blog will focus on the impact of COVID-19 on Diabetes (those at risk and people living with diabetes already), from the ePosters presented during the conference.  COVID19 and the impact on youth onset type 2 diabetes new diagnoses and severity @Sean DeLacey Initial studies of pediatric diabetes and COVID-19 focused on type 1 diabetes with some initial reports showing an increase in youth onset type 2 diabetes (T2D). New diagnoses of T2D increased during the COVID-19 pandemic; New diagnoses increased disproportionately in the non-Hispanic Black population; HbA1C values at diagnosis increased, but rates of acidosis and hyperosmolarity did not; Clinical COVID infection was uncommon among those with a new diagnosis of Type 2